|
Orthologous residues
|
|
cortactin (human): Y470‑p, cortactin iso3 (human): Y433‑p, cortactin (mouse): Y466‑p, cortactin (rat): Y428‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, peptide sequencing, phospho-antibody, phosphoamino acid analysis
|
|
Relevant cell lines - cell types - tissues:
3T3 (fibroblast) [cortactin (human)], 3T3 (fibroblast) [Src (human)]
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
mouse
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Comments:
It appears that v-src may have been used for in vitro and well as in in vivo studies.
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Comments:
Previous work by the authors showed that src attenuates the actin cross-linking activity of cortactin. These studies show that transfection with a cortactin mutant (F421/F470/F486) impairs the motility of endothelial cells.
|